Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFER | P55789 | 1/20 | 0.74 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.64 |
| ▸ | MAOB | P27338 | 6/20 | 0.61 |
| ▸ | MAOA | P21397 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | CHKA | P35790 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | GRK6 | P43250 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3482833 | 0.86 | GFER (1.00) | GFERCYP19A1MAOBMAOAALDH1A1 | |
| SCHEMBL8164156 | 0.86 | GFER (1.00) | GFERCYP19A1MAOBMAOAALDH1A1 | |
| SCHEMBL187043 | 0.86 | GFER (1.00) | GFERCYP19A1MAOBMAOAALDH1A1 | |
| SCHEMBL720452 | 0.83 | LTA4H (0.64) | GFERCYP19A1MAOBMAOAALDH1A1 | |
| Hydrochloric Acid SCHEMBL8653872 | 0.83 | GFER (0.93) | GFERCYP19A1MAOBMAOAALDH1A1 | |
| SCHEMBL19105196 | 0.82 | MAOB (0.71) | GFERCYP19A1MAOBMAOAALDH1A1 | |
| SCHEMBL12110688 | 0.78 | GFER (0.82) | GFERCYP19A1MAOBMAOAALDH1A1 | |
| SCHEMBL6362605 | 0.78 | CYP3A4 (0.82) | GFERCYP19A1MAOBMAOAALDH1A1 | |
| SCHEMBL18469205 | 0.78 | TAAR1 (0.43) | GFERALDH1A1TDP1LOXL2RECQL | |
| SCHEMBL12110804 | 0.76 | GFER (0.78) | GFERCYP19A1MAOBMAOAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11667737-B1 | Thermosetting polyimides derived from resveratrol | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2023-06-06 | — | — | US | disclosed |
| US-11667737-B1 | Thermosetting polyimides derived from resveratrol | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2023-06-06 | — | — | US | disclosed |
| US-11192967-B1 | Thermosetting polyimides derived from resveratrol | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2021-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667737-B1 | Thermosetting polyimides derived from resveratrol | RICTOR, MAP1LC3C, DEPTOR | GFER 1859/4885CYP19A1 2828/4885MAOB 3270/4885 |
| US-11192967-B1 | Thermosetting polyimides derived from resveratrol | RICTOR, MAP1LC3C, DEPTOR | GFER 1859/4885CYP19A1 2828/4885MAOB 3270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.